Adar1 Capital Management, LLC Top Holdings and 13F Report (2024)

About Adar1 Capital Management, LLC

Investment Activity

Adar1 Capital Management, LLC has $529.70 million in total holdings as of March 31, 2024.
Adar1 Capital Management, LLC owns shares of 250 different stocks, but just 29 companies or ETFs make up 80% of its holdings.
Approximately 50.70% of the portfolio was purchased this quarter.
About 36.58% of the portfolio was sold this quarter.
This quarter, Adar1 Capital Management, LLC has purchased 247 new stocks and bought additional shares in 86 stocks.
Adar1 Capital Management, LLC sold shares of 48 stocks and completely divested from 60 stocks this quarter.

Largest Holdings

Protagonist Therapeutics: $55,576,244
Cytokinetics: $46,267,661
Roivant Sciences: $43,865,595
Alpha Architect 1-3 Month Box ETF: $37,895,032
BridgeBio Pharma: $32,155,675

Largest New Holdings this Quarter

Rezolute: $8,875,037 Holding
PERCEPTIVE CAP SOLUTIONS COR: $7,545,000 Holding
TECTONIC THERAPEUTIC INC: $5,877,781 Holding
Crinetics Pharmaceuticals: $3,352,532 Holding
KALA BIO: $2,170,015 Holding

Largest Purchases this Quarter

Cytokinetics: 531,952 shares (about $28.82M)
Protagonist Therapeutics: 818,277 shares (about $28.35M)
Insmed: 391,317 shares (about $26.22M)
BridgeBio Pharma: 718,466 shares (about $18.20M)
Roivant Sciences: 1,358,139 shares (about $14.36M)

Largest Sales this Quarter

Alnylam Pharmaceuticals: 423,895 shares (about $103.01M)
SPDR S&P 500 ETF Trust: 44,000 shares (about $23.95M)
Sarepta Therapeutics: 27,855 shares (about $4.40M)
Endeavor Group: 144,635 shares (about $3.91M)
Invesco QQQ: 7,000 shares (about $3.35M)

Sector Allocation Over Time

Selling

Neutral

Buying

Latest 13F Holdings and Changes Since Previous Quarterly Filing

Issuer Name	Holdings Value	Approximate Purchase/Sale	Change in Shares	Shares Held	% of Portfolio	Sector
PTGX Protagonist Therapeutics	$55,576,244	$28,353,298 ▲	104.2%	1,603,932	10.5%	Medical
CYTK Cytokinetics	$46,267,661	$28,821,159 ▲	165.2%	853,962	8.7%	Medical
ROIV Roivant Sciences	$43,865,595	$14,355,529 ▲	48.6%	4,150,009	8.3%	Medical
BOXX Alpha Architect 1-3 Month Box ETF	$37,895,032	$3,596,924 ▲	10.5%	351,482	7.2%	ETF
BBIO BridgeBio Pharma	$32,155,675	$18,198,744 ▲	130.4%	1,269,470	6.1%	Medical
RPRX Royalty Pharma	$31,151,725	$12,131,018 ▲	63.8%	1,181,332	5.9%	Finance
INSM Insmed	$26,332,139	$26,218,239 ▲	23,018.6%	393,017	5.0%	Medical
KROS Keros Therapeutics	$25,085,461	$9,627,756 ▲	62.3%	548,916	4.7%	Medical
IMVT Immunovant	$12,580,735	$10,976,592 ▲	684.3%	476,543	2.4%	Medical
ABUS Arbutus Biopharma	$10,163,813	$3,754,588 ▲	58.6%	3,289,260	1.9%	Medical
MRK Merck & Co., Inc.	$9,377,850	$9,340,710 ▲	25,150.0%	75,750	1.8%	Medical
RZLT Rezolute	$8,875,037	$8,875,037 ▲	New Holding	2,063,962	1.7%	Medical
SLDB Solid Biosciences	$8,053,793	$6,901,626 ▲	599.0%	1,420,422	1.5%	Medical
EWTX Edgewise Therapeutics	$7,863,310	$4,605,103 ▲	141.3%	436,608	1.5%	Medical
PERCEPTIVE CAP SOLUTIONS COR	$7,545,000	$7,545,000 ▲	New Holding	750,000	1.4%	CL A ORD SHS
ASND Ascendis Pharma A/S	$6,991,248	$365,362 ▲	5.5%	51,263	1.3%	Medical
TECTONIC THERAPEUTIC INC	$5,877,781	$5,877,781 ▲	New Holding	356,878	1.1%	COM
CERE Cerevel Therapeutics	$5,869,760	$2,825,131 ▲	92.8%	143,550	1.1%	Medical
QURE uniQure	$5,477,588	$4,165,620 ▲	317.5%	1,222,676	1.0%	Medical
ABSI Absci	$5,231,469	$3,423,558 ▲	189.4%	1,698,529	1.0%	Medical
VKTX Viking Therapeutics	$4,835,943	$4,072,546 ▲	533.5%	91,227	0.9%	Medical
ALKS Alkermes	$4,737,506	$963,446 ▲	25.5%	196,577	0.9%	Medical
SPY SPDR S&P 500 ETF Trust	$4,353,760	$23,945,680 ▼	-84.6%	8,000	0.8%	Finance
HELIX ACQUISITION CORP II	$4,130,290	$6,520 ▲	0.2%	404,138	0.8%	CL A ORD SHS
ANAB AnaptysBio	$3,941,913	$3,866,733 ▲	5,143.3%	157,299	0.7%	Medical
CRNX Crinetics Pharmaceuticals	$3,352,532	$3,352,532 ▲	New Holding	74,850	0.6%	Medical
BIL SPDR Bloomberg Barclays 1-3 Month T-Bill ETF	$2,982,850		0.0%	32,500	0.6%	ETF
Q32 BIO INC	$2,809,247	$557,581 ▼	-16.6%	156,504	0.5%	COM
ACASTI PHARMA INC	$2,801,947	$2,167,195 ▲	341.4%	959,571	0.5%	CL A
SVRA Savara	$2,738,780	$2,716,212 ▲	12,035.7%	679,598	0.5%	Medical
VUSB Vanguard Ultra-Short Bond ETF	$2,733,801		0.0%	55,206	0.5%	ETF
JPST JPMorgan Ultra-Short Income ETF	$2,725,380		0.0%	54,000	0.5%	ETF
SHV iShares Short Treasury Bond ETF	$2,707,250		0.0%	24,500	0.5%	ETF
OABI OmniAb	$2,672,100	$979,031 ▲	57.8%	712,560	0.5%	Medical
USFR WisdomTree Bloomberg Floating Rate Treasury Fund	$2,666,430		0.0%	53,000	0.5%	Finance
ACHV Achieve Life Sciences	$2,548,495	$1,564,005 ▼	-38.0%	542,233	0.5%	Medical
FULC Fulcrum Therapeutics	$2,407,888	$300,973 ▲	14.3%	388,369	0.5%	Medical
CNTA Centessa Pharmaceuticals	$2,286,369	$418,459 ▲	22.4%	253,197	0.4%	Medical
KALA KALA BIO	$2,170,015	$2,170,015 ▲	New Holding	306,067	0.4%	Medical
KINIKSA PHARMACEUTICALS INTL	$2,134,149	$2,134,149 ▲	New Holding	114,309	0.4%	ORD SHS CL A
ULST SPDR SSgA Ultra Short Term Bond ETF	$1,929,771		0.0%	47,684	0.4%	ETF
BEAM Beam Therapeutics	$1,705,704	$1,705,704 ▲	New Holding	72,800	0.3%	Medical
CLRB Cellectar Biosciences	$1,705,235	$98,883 ▲	6.2%	682,094	0.3%	Medical
TEVA Teva Pharmaceutical Industries	$1,675,716	$24,294 ▲	1.5%	103,121	0.3%	Medical
DCTH Delcath Systems	$1,660,164	$172,640 ▼	-9.4%	198,347	0.3%	Medical
SLNO Soleno Therapeutics	$1,629,103	$1,629,103 ▲	New Holding	39,929	0.3%	Medical
APOGEE THERAPEUTICS INC	$1,608,431	$1,372,331 ▲	581.3%	40,875	0.3%	COM
MRUS Merus	$1,588,714	$1,588,714 ▲	New Holding	26,850	0.3%	Medical
BGNE BeiGene	$1,583,637	$2,911,181 ▼	-64.8%	11,100	0.3%	Medical
AURA Aura Biosciences	$1,536,472	$1,536,472 ▲	New Holding	203,237	0.3%	Medical
KYMR Kymera Therapeutics	$1,511,186	$1,033,586 ▲	216.4%	50,626	0.3%	Medical
APLT Applied Therapeutics	$1,497,795	$775,038 ▼	-34.1%	320,727	0.3%	Medical
QQQ Invesco QQQ	$1,437,330	$3,353,770 ▼	-70.0%	3,000	0.3%	Finance
CNTX Context Therapeutics	$1,293,548	$880,650 ▲	213.3%	645,161	0.2%	Medical
ATXS Astria Therapeutics	$1,257,238	$1,214,905 ▲	2,869.9%	138,158	0.2%	Medical
IBIO INC	$1,202,700	$63,300 ▼	-5.0%	570,000	0.2%	CON NEW
SPRO Spero Therapeutics	$1,194,608	$10,400 ▼	-0.9%	918,929	0.2%	Medical
INDV Indivior	$1,128,513	$683,585 ▲	153.6%	70,007	0.2%	Medical
PFE Pfizer	$1,117,801	$1,857,648 ▼	-62.4%	39,950	0.2%	Medical
NVNO enVVeno Medical	$1,059,072		0.0%	201,728	0.2%	Medical
TH Target Hospitality	$989,682	$989,682 ▲	New Holding	113,626	0.2%	Consumer Discretionary
GH Guardant Health	$981,920	$2,397,040 ▼	-70.9%	34,000	0.2%	Medical
VIR Vir Biotechnology	$979,000	$979,000 ▲	New Holding	110,000	0.2%	Medical
CGEM Cullinan Therapeutics	$928,872	$928,872 ▲	New Holding	53,261	0.2%	Medical
PCVX Vaxcyte	$924,998	$773,978 ▲	512.5%	12,250	0.2%	Medical
ITOS iTeos Therapeutics	$890,400	$890,400 ▲	New Holding	60,000	0.2%	Medical
ALEC Alector	$886,712	$648,362 ▲	272.0%	195,311	0.2%	Medical
DNLI Denali Therapeutics	$882,360	$835,920 ▲	1,800.0%	38,000	0.2%	Medical
ANGO AngioDynamics	$870,365	$57,475 ▼	-6.2%	143,862	0.2%	Medical
ARVN Arvinas	$862,488	$165,044 ▲	23.7%	32,400	0.2%	Medical
SPYRE THERAPEUTICS INC	$827,082	$336,663 ▼	-28.9%	35,180	0.2%	COM NEW
AGR Avangrid	$817,190	$817,190 ▲	New Holding	23,000	0.2%	Utilities
APLS Apellis Pharmaceuticals	$795,970	$189,882 ▼	-19.3%	20,750	0.2%	Medical
KEEN VISION ACQUISITION CORP	$792,750		0.0%	75,000	0.1%	UNIT 99/99/9999
SLN Silence Therapeutics	$765,510	$3,800 ▲	0.5%	40,290	0.1%	Medical
KIORA PHARMACEUTICALS INC	$724,903	$724,903 ▲	New Holding	172,596	0.1%	COM
SRPT Sarepta Therapeutics	$703,100	$4,401,090 ▼	-86.2%	4,450	0.1%	Medical
CTMX CytomX Therapeutics	$698,047	$508,947 ▲	269.1%	572,170	0.1%	Medical
PERSPECTIVE THERAPEUTICS INC	$697,750	$697,750 ▲	New Holding	69,985	0.1%	COM NEW
ELYM Eliem Therapeutics	$694,611	$694,611 ▲	New Holding	97,695	0.1%	Medical
XAIR Beyond Air	$658,338	$10,988 ▲	1.7%	1,225,270	0.1%	Medical
KZR Kezar Life Sciences	$651,899	$509,925 ▲	359.2%	1,086,498	0.1%	Medical
VXRT Vaxart	$630,978	$630,978 ▲	New Holding	945,568	0.1%	Medical
CTVA Corteva	$614,916	$1,402,440 ▼	-69.5%	11,400	0.1%	Consumer Staples
ARYD ARYA Sciences Acquisition Corp IV	$613,955	$144,488 ▲	30.8%	53,527	0.1%	Medical
IWM iShares Russell 2000 ETF	$608,670	$608,670 ▲	New Holding	3,000	0.1%	Finance
AKRO Akero Therapeutics	$598,394	$556,002 ▲	1,311.6%	25,507	0.1%	Medical
MRNA Moderna	$593,750	$593,750 ▲	New Holding	5,000	0.1%	Medical
TSHA Taysha Gene Therapies	$561,792	$464,352 ▲	476.6%	250,800	0.1%	Medical
ACTINIUM PHARMACEUTICALS INC	$555,984	$184,016 ▼	-24.9%	75,133	0.1%	COM
TMTC TMT Acquisition	$549,000		0.0%	50,000	0.1%	Unclassified
CRBP Corbus Pharmaceuticals	$543,000	$181,000 ▼	-25.0%	12,000	0.1%	Medical
RYTM Rhythm Pharmaceuticals	$533,780	$24,636 ▲	4.8%	13,000	0.1%	Medical
ARDX Ardelyx	$518,700	$518,700 ▲	New Holding	70,000	0.1%	Medical
YEAR AB Ultra Short Income ETF	$505,150		0.0%	10,000	0.1%	ETF
GOSS Gossamer Bio	$497,863	$162,162 ▼	-24.6%	552,628	0.1%	Medical
PULS PGIM Ultra Short Bond ETF	$497,000		0.0%	10,000	0.1%	ETF
STVN Stevanato Group	$495,180	$210,910 ▲	74.2%	27,000	0.1%	Medical
DAWN Day One Biopharmaceuticals	$483,678	$483,678 ▲	New Holding	35,100	0.1%	Medical
ABEO Abeona Therapeutics	$479,650	$479,650 ▲	New Holding	113,125	0.1%	Medical

Showing largest 100 holdings. View all holdings.

More Institutional Buying and Selling Information

SEC Filings and Trading Data

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Adar1 Capital Management, LLC Top Holdings and 13F Report (2024)

About Adar1 Capital Management, LLC

Investment Activity

Largest Holdings

Largest New Holdings this Quarter

Largest Purchases this Quarter

Largest Sales this Quarter

Sector Allocation Over Time

Latest 13F Holdings and Changes Since Previous Quarterly Filing

More Institutional Buying and Selling Information

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Adar1 Capital Management, LLC Top Holdings and 13F Report (2024)

About Adar1 Capital Management, LLC

Investment Activity

Largest Holdings

Largest New Holdings this Quarter

Largest Purchases this Quarter

Largest Sales this Quarter

Sector Allocation Over Time

Map of 500 Largest Holdings ofAdar1 Capital Management, LLC

Latest 13F Holdings and Changes Since Previous Quarterly Filing

More Institutional Buying and Selling Information

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools